Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

Returns vs FD rates

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Traders may keep positions light owing to the weekend factor as uncertainty lingers around the threat of Omicron variant

Stocks to Watch:GSK Pharma, Jet Airways, Rel Infra, auto, bank, FMCG shares

COVID-19 Live updates: UK approves use of GlaxoSmithKline monoclonal antibody to treat COVID-19

The UK regulator has given its nod to GSK Pharma's Covid-19 antibody drug which is expected to cut hospitaisation and deaths by 79%. Here's what it would now mean for the company.

#CNBCTV18 #BusinessNews #ShareMarketToday #Nifty #Sensex #GSKPharma

CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.

For latest news and updates visit our Website: https://bit.ly/2YbpXBM
Subscribe to our Channel: https://www.youtube.com/user/CNBCTV18
Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News

UK Regulator Gives Nod To GSK Pharma's COVID Drug | Midcap Radar | CNBC-TV18

Drugmaker GlaxoSmithKline added 0.7% after a pre-clinical analysis of the antibody-based COVID-19 therapy it is developing with U.S. partner Vir indicated that the drug also works against the new Omicron variant.

UK shares slide as inflation, Omicron risks grow

The Omicron variant of COVID-19 is said to be more contagious than others variants. There are concerns over the efficacy of existing vaccines to fight the new variant. Many countries have already announced travel curbs. Is the world better prepared for tackling virus and are measures like mini-Lock downs needed again? Speaking to ETNOW, A Vaidheesh, former Managing Director of GlaxoSmithKline Pharmaceuticals advised people to remain cautious and follow all the safety protocols. He believes there is no need for booster shots as of now as more information on the variant will be coming out. Watch.

Omicron Scare | Is World Better Prepared For Tackling Virus? A Vaidheesh, Former MD, GSK Pharma

GSK would start testing therapies on humans to wake up a latent HIV virus within people’s immune cells. Once the virus is brought out, efforts would be directed towards neutralising it.

GlaxoSmithKline To Initiate Human Trials To Find HIV Cure

Glaxosmithkline Pharmaceuticals jumped 10.17% to Rs 1,780.3, rising for third trading session.

GSK Pharma hits 52-week high; rises 11% in three days

The management expects this positive momentum to continue through the second half of the year driving the company towards the better end of a meaningful performance improvement.

GSK Pharma surges 11%, hits 52-week high on improved outlook

Reliance Industrial Infrastructure Ltd, Jai Corp Ltd, Glaxosmithkline Pharmaceuticals Ltd and Aurum Proptech Ltd are among the other gainers in the BSE’s ‘A’ group today, 25 November 2021.

R Systems International Ltd leads gainers in ‘A’ group

GSK Pharma Q2 Review - Operating Leverage Expands Margin: Centrum Broking

Glaxosmithkline Pharmaceuticals Ltd notched up volume of 8994 shares by 10:50 IST on BSE, a 4.74 fold spurt over two-week average daily volume of 1898 shares

Volumes spurt at Glaxosmithkline Pharmaceuticals Ltd counter

GlaxoSmithKline Pharmaceuticals is a pharmaceutical company engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in pharmaceuticals, vaccines and consumer healthcare.

GlaxoSmithKline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Stocks to Watch:GSK Pharma, Jet Airways, Rel Infra, auto, bank, FMCG shares

COVID-19 Live updates: UK approves use of GlaxoSmithKline monoclonal antibody to treat COVID-19

News Video

UK Regulator Gives Nod To GSK Pharma's COVID Drug | Midcap Radar | CNBC-TV18

UK shares slide as inflation, Omicron risks grow

News Video

Omicron Scare | Is World Better Prepared For Tackling Virus? A Vaidheesh, Former MD, GSK Pharma

GlaxoSmithKline To Initiate Human Trials To Find HIV Cure

GSK Pharma hits 52-week high; rises 11% in three days

GSK Pharma surges 11%, hits 52-week high on improved outlook

R Systems International Ltd leads gainers in ‘A’ group

GSK Pharma Q2 Review - Operating Leverage Expands Margin: Centrum Broking

GlaxoSmithKline Pharmaceuticals Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Stocks to Watch:GSK Pharma, Jet Airways, Rel Infra, auto, bank, FMCG shares

COVID-19 Live updates: UK approves use of GlaxoSmithKline monoclonal antibody to treat COVID-19

News Video

UK Regulator Gives Nod To GSK Pharma's COVID Drug | Midcap Radar | CNBC-TV18

UK shares slide as inflation, Omicron risks grow

News Video

Omicron Scare | Is World Better Prepared For Tackling Virus? A Vaidheesh, Former MD, GSK Pharma

GlaxoSmithKline To Initiate Human Trials To Find HIV Cure

GSK Pharma hits 52-week high; rises 11% in three days

GSK Pharma surges 11%, hits 52-week high on improved outlook

R Systems International Ltd leads gainers in ‘A’ group

GSK Pharma Q2 Review - Operating Leverage Expands Margin: Centrum Broking

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock